Ipratropium and Albuterol

Combivent Respimat

Anticholinergic

NADAC/unit $0.0844

No Shortage Tier 1: 46.2% PA Req: 99.7% 4 Manufacturers 4 ANDAs

vs. brand Combivent Respimat: Generic saves up to 99% per unit

Covered Lives

Market Intelligence

2024-05-01 Class II Recall: Cipla USA, Inc.

2024-01-03 Class II Recall: CARDINAL HEALTHCARE

Generic Manufacturers

BOEHRINGER INGELHEIM PHARMACEUTICALS INCCIPLA LTDNEPHRON PHARMACEUTICALS CORPSUN PHARMACEUTICAL INDUSTRIES LTDTHE RITEDOSE CORP

Explore in the Ecosystem

rxsaver.aiCompare prices for Ipratropium and Albuterol drfinder.aiFind doctors who prescribe Ipratropium and Albuterol rxnews.aiLatest news about Ipratropium and Albuterol

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.